companydata.dkRenescience A/S: Financial statements 2023
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 10,419,000 and a net result of DKK -194,649,000 compared with DKK -13,301,000 the year before. That is a decrease of 3.8% compared with the year before. The profit margin was -1,868.2%. Equity amounted to DKK -11,689,000.
- Revenue
- 10,419,000 kr.
- Gross Profit
- -13,537,000 kr.
- Profit/Loss
- -194,649,000 kr.
- Equity
- -11,689,000 kr.
- Total Assets
- 32,791,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 10.4 mio. | -13.5 mio. | -194.6 mio. | -11.7 mio. | 0 |
| 2022 | 10.8 mio. | -10.9 mio. | -13.3 mio. | 183 mio. | 0 |
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
| 2020 | 1.7 mio. | -16.6 mio. | -13.5 mio. | 31.1 mio. | - |
| 2019 | - | -23.2 mio. | -18.1 mio. | 44.6 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Renescience A/S has published its annual report for 2022. Revenue came to DKK 10,831,000, and the net result was DKK -13,301,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.